Kyle Griffin @kylegriffin1
Pfizer and BioNTech are expected this week to apply for regulatory approval for a booster shot of their coronavirus vaccine for 16- and 17-year-olds. If approved, the shot would be the first booster available to people under 18. https://t.co/ozw6nNQV9T — PolitiTweet.org